3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
14
Lymphoma, Follicular
6
Neoplasm Metastasis
5
Lymphoma, Large B-Cell, Diffuse
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Hemangioma
3
Neoplasms
2
Urogenital Neoplasms
1
Thymoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Myasthenia Gravis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, T-Cell
1
Leukemia, Lymphoid
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Hodgkin Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
enzalutamide
3
cabazitaxel
3
Prednisone
3
Docetaxel
2
Abiraterone Acetate
2
rucaparib
1
Zuclomiphene
1
XRP6258
1
Standard of Care
1
LY3023414
1
Injections
1
Abituzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostate Cancer Metastatic
×
Prednisolone
×
Clear all
No trials found.